English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/99482
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

The glycogen phosphatase activity of laforin is dispensable to rescue the Lafora disease phenotype of Epm2a -/- mice.

AuthorsGayarre, Javier; Durán-Trío, Lara ; Criado-García, Olga ; Aguado, Carmen; Juana-López, Lucía ; Crespo Galán, Inmaculada ; Knecht, Erwin; Bovolenta, Paola ; Rodríguez de Córdoba, Santiago
KeywordsLafora disease
Phosphatase activity
Glycogen phosphorylation
Lafora bodies
Issue Date14-Jan-2014
PublisherOxford University Press
CitationBrain 2014: 137; 806–818
AbstractLafora progressive myoclonus epilepsy (Lafora disease) is a fatal autosomal recessive neurodegenerative disorder characterized by the presence of glycogen-like intracellular inclusions called Lafora bodies. The vast majority of patients carry mutations in either the EPM2A or EPM2B genes, encoding laforin, a glucan phosphatase, and malin, an E3 ubiquitin ligase, respectively.Although the precise physiological role of these proteins is not fully understood, work in past years has established a link between glycogen synthesis, Lafora bodies formation and Lafora disease development. To determine the role of the phosphatase activity of laforin in disease development we generated two Epm2a / mouse lines expressing either wild-type laforin or a mutant (C265S) laforin lacking only the phosphatase activity. Our results demonstrate that expression of either transgene blocks formation of Lafora bodies and restores the impairment in macroautophagy, preventing the development of Lafora bodies in Epm2a / mice. These data indicate that the critical pathogenic process is the control of abnormal glycogen accumulation through intracellular proteolytic systems by the laforin–malin complex, and not glycogen dephosphorylation by laforin.Understanding which is the essential process leading to Lafora disease pathogenesis represents a critical conceptual advance that should facilitate development of appropriate therapeutics.
Description45 p.-1 tab.-9 fig.
Publisher version (URL)http://dx.doi.org/10.1093/brain/awt353
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
Brain-Gayarre-2014.pdf1,83 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.